Home > M&A deals 2016 > KKR & Co. Inc. and Vivo Capital invest in Impel NeuroPharma, Inc.
Venture · Life Science · December 2016

KKR & Co. Inc. and Vivo Capital invest in Impel NeuroPharma, Inc.

On December 2, 2016, KKR & Co. Inc. and Vivo Capital invested in Impel NeuroPharma, Inc., a life science company in Washington, United States.

Deal at a glance

AnnouncedDecember 2, 2016 TypeVenture TargetImpel NeuroPharma, Inc. Buyers KKR & Co. Inc.
Vivo Capital SectorLife Science LocationWashington, United States ValueNot disclosed

Target company

Impel NeuroPharma, Inc.
Washington, United States
Life Sciencesector
2011founded
Activestatus
View the company profile →

Buyers (2)

KKR & Co. Inc. Lead
Private equity firm · 427 deals on record
Vivo Capital Co-investor
Company · 20 deals on record
  • 8th transaction for the lead buyer in life science
  • 93rd transaction in United States
427deals, all time
14in this sector
2026latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Gen II Fund Services LLCSame lead buyer · Oct 2026
Ci FLAVORS Co., Ltd.Same lead buyer · Aug 2026
Medicover IndiaSame lead buyer · Aug 2026
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Impel NeuroPharma, Inc.?KKR & Co. Inc. and Vivo Capital invested in Impel NeuroPharma, Inc. on December 2, 2016.

What type of deal was it?It was a venture in the life science sector in 2016.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).